MEDINET is the only CDMO offering solutions for the entire regenerative medicine and cell therapy valued chain, from pre-clinical research through to development, manufacturing, and commercial launch.
We have a proven track record since 1999 of satisfying client needs with our comprehensive solutions of the highest quality and efficiency. We work with you to accomplish one-stop solutions at every development stage of your regenerative medicine and cell therapy.
Our cell processing facility (CPF) is the most advanced of its kind in Japan. Shinagawa CPF is equipped to comply with Japanese, US, and European cell processing regulations such as GCTP. MEDINET’s competitive advantage in CDMO is also its personnel.
MEDINET is your ideal choice for contract manufacture under the new Japanese regulatory framework for regenerative medicine. Our experienced specialists with expertise in the new framework can work closely with you to provide support to help you develop and manufacture your products in Japan.